Inventor
BANDER NEIL H
US22 patents
⚠️ This page may combine multiple inventors who share the name “BANDER NEIL H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CORNELL RES FOUNDATION INC
10 patentsUS7163680B2Jan 16, 2007
Treatment and diagnosis of cancer
CORNELL RES FOUNDATION INC96 citations99
US6136311AOct 24, 2000
Treatment and diagnosis of cancer
CORNELL RES FOUNDATION INC120 citations99
US6107090AAug 22, 2000
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
CORNELL RES FOUNDATION INC174 citations99
US7666425B1Feb 23, 2010
Treatment and diagnosis of prostate cancer
CORNELL RES FOUNDATION INC51 citations98
US7514078B2Apr 7, 2009
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
CORNELL RES FOUNDATION INC75 citations97
US7112412B1Sep 26, 2006
Treatment and diagnosis of prostate cancer
CORNELL RES FOUNDATION INC39 citations96
US6770450B1Aug 3, 2004
Treatment and diagnosis of cancer
CORNELL RES FOUNDATION INC50 citations96
US6767711B2Jul 27, 2004
Treatment and diagnosis of prostate cancer
CORNELL RES FOUNDATION INC61 citations96
US6649163B1Nov 18, 2003
Treatment and diagnosis of cancer
CORNELL RES FOUNDATION INC51 citations96
US5773292AJun 30, 1998
Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
CORNELL RES FOUNDATION INC69 citations96
SLOAN KETTERING INST CANCER
3 patentsUS4713352ADec 15, 1987
Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
SLOAN KETTERING INST CANCER36 citations92
US5145773ASep 8, 1992
Method to detect sensitivity to alpha-interferon therapy
SLOAN KETTERING INST CANCER7 citations66
US4935344AJun 19, 1990
Method for characterizing types of renal carcinoma and prognosis
SLOAN KETTERING INST CANCER5 citations61
UNIV CORNELL
3 patentsUS12285503B2Apr 29, 2025
Methods and reagents for tumor targeting with greater efficacy and less toxicity
UNIV CORNELL1 citations75
US11738101B2Aug 29, 2023
Methods and reagents for tumor targeting with greater efficacy and less toxicity
UNIV CORNELL2 citations73
US11491247B2Nov 8, 2022
Methods and reagents for tumor targeting with greater efficacy and less toxicity
UNIV CORNELL3 citations73
UNIV COLUMBIA
2 patentsUS6087098AJul 11, 2000
Enhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinoma
UNIV COLUMBIA32 citations87
US6451532B1Sep 17, 2002
Enhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinoma
UNIV COLUMBIA2 citations57